Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

454.00
-4.0500-0.88%
Pre-market: 453.51-0.4900-0.11%06:03 EDT
Volume:2.20M
Turnover:1.00B
Market Cap:115.19B
PE:29.63
High:461.05
Open:454.62
Low:452.89
Close:458.05
52wk High:513.98
52wk Low:362.50
Shares:253.72M
Float Shares:253.72M
Volume Ratio:1.61
T/O Rate:0.87%
Dividend:- -
Dividend Rate:- -
EPS(TTM):15.32
EPS(LYR):15.32
ROE:22.54%
ROA:12.16%
PB:6.17
PE(LYR):29.63

Loading ...

Apr 27, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 12, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 12, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 04, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 24, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 17, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 16, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 13, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 10, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2023

Major Issues Report

8-K - Current report
Oct 28, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 27, 2022

Major Issues Report

8-K - Current report
Sep 26, 2022

Correspondence

CORRESP [Cover] - Correspondence
Aug 05, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 04, 2022

Major Issues Report

8-K - Current report
Jul 11, 2022

Major Issues Report

8-K - Current report